Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma

Eur J Surg Oncol. 2006 Apr;32(3):303-7. doi: 10.1016/j.ejso.2006.01.002. Epub 2006 Feb 14.

Abstract

Aims: In the current study, we investigated possible correlations of the mtDNA copy number in hepatocellular carcinoma (HCC) with the pathological findings and prognosis.

Methods: We studied 31 HCC specimens using quantitative real-time polymerase chain reaction analysis, and the correlation between the mtDNA copy number and the clinicopathologic parameters and mutations in the D-loop region of the mitochondrial genome.

Results: The mtDNA copy number was reduced in HCCs compared with the corresponding non-cancerous liver tissues (p=0.002), and significantly correlated with tumour size (p=0.014) and cirrhosis (p=0.048). Patients with a low mtDNA copy number tended to show shorter 5-year survival rates than patients with a high mtDNA copy number when assessed by Kaplan-Meier curves, but not a significant (overall survival rate, 63 vs 83%; p=0.19). The copy number of HCC with mtDNA D-loop mutation or deletion was lower, but not significantly so (p=0.656, p=0.590, respectively).

Conclusions: Our results indicated that a reduced copy number of mtDNA is correlated with HCC and associated with malignant potential.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology
  • DNA, Mitochondrial / genetics*
  • DNA, Neoplasm / genetics*
  • Disease Progression
  • Follow-Up Studies
  • Gene Dosage
  • Hepatectomy
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Middle Aged
  • Polymerase Chain Reaction
  • Prognosis
  • Retrospective Studies
  • Survival Rate

Substances

  • DNA, Mitochondrial
  • DNA, Neoplasm